skip to primary navigationskip to content

Molecular Immunity Unit- Department of Medicine

Molecular Immunity Unit at the MRC Laboratory of Molecular Biology

Infectious diseases remain the major cause of mortality and morbidity throughout the world and their occurrence represents a failure of the immune system. In spite of this, however, our very existence demonstrates that our immune system has the capability to successfully cope with these diseases.

The goal of the Department of Medicine Molecular Immunity Unit (MIU) is to better understand the fundamental mechanisms that govern microbial pathogenesis, how the immune system can control these infections and what happens when the immune system fails and turns against our own bodies. This requires a wide spectrum of research using complementary approaches that span all scales of biology; from atomic-level structural analysis to studies of human patient cohorts.

This spectrum covers the interface between molecular biology and clinical medicine. Embedded within the MRC Laboratory of Molecular Biology, the MIU views itself as a bridge between these two areas. The Unit's size and distribution of interests are intended to be broad enough to bring about important and medically relevant research but small enough to be a cohesive research facility.

Upcoming events

The 19th Cambridge Immunology Forum – ‘Cancer Immunology’

Sep 20, 2018

Queens' College Cambridge.

Upcoming events

The new Capella building- CITIID

See the home of CITIID being built in this fantastic time-lapse video. From basement to water tight in 17 months. The Capella building will be finished in 2018.

FCEs provide interdisciplinary training programmes for students, fellows and continuing education physicians through FOCIS assisted opportunities

Read more